News Headlines
- West Expands Corning Collaboration And Launches First Product 2/8/2023
-
Kymanox Acquires EU Based Anteris Medical And Anteris Helvetia
2/7/2023
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence.
- Kayentis And ClinOne Join Forces To Improve Efficiency And Patient Experience In Clinical Trials 1/18/2023
- Premier Research And CENTOGENE Launch Strategic Partnership To Accelerate And De-Risk Rare Disease Clinical Development 1/12/2023
- Trialbee Announces Trialbee Honey™ Omnichannel, Real-Time Patient Recruitment Tracking For Multiple Recruitment Sources At CNS Summit 2022 12/14/2022
- Trialbee And Acclinate Partner To Enhance Equitable Clinical Trial Participation 12/14/2022
-
Kindeva And Meridian Combine: Create Leading Drug-Device Combination Product CDMO
12/13/2022
The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”.
-
BIOCORP Obtains 510(k) FDA Clearance For Mallya®
12/7/2022
BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, announced today that they have received 510(K) clearance from the U.S. Food & Drug Administration (FDA) to market Mallya, its smart medical device that connects insulin pens.
- Tech Wizards: Matt Walz 11/23/2022
- Trialbee Further Expands Leadership Team With New VP Of Global Sales Jo Holton 11/16/2022
This website uses cookies to ensure you get the best experience on our website. Learn more